WEISSKOFF ROBERT 4
4 · EPIX MEDICAL INC · Filed Sep 1, 2004
Insider Transaction Report
Form 4
EPIX MEDICAL INCEPIX
WEISSKOFF ROBERT
VP of Business DevelopOther
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2004-08-30$8.50/sh−1,000$8,500→ 20,504 totalExercise: $8.50From: 2002-01-02Exp: 2011-01-02→ Common Stock (1,000 underlying) - Exercise/Conversion
Common Stock
2004-08-30$8.50/sh+1,000$8,500→ 1,000 total - Sale
Common Stock (Sale Pursuant to a 10b5-1 Trading Plan)
2004-08-30$19.15/sh−700$13,405→ 0 total - Exercise/Conversion
Common Stock
2004-08-31$8.50/sh+2,000$17,000→ 2,000 total - Sale
Common Stock (Sale Pursuant to a 10b5-1 Trading Plan)
2004-08-31$20.02/sh−2,000$40,040→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2004-08-31$8.50/sh−2,000$17,000→ 18,504 totalExercise: $8.50From: 2002-01-02Exp: 2011-01-02→ Common Stock (2,000 underlying) - Sale
Common Stock (Sale Pursuant to a 10b5-1 Trading Plan)
2004-08-30$19.05/sh−300$5,715→ 700 total
Footnotes (2)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 4, 2003.
- [F2]From January 2, 2001 grant of 35,000 options to purchase shares of common stock of which 16,054 options have been exercised, 4,504 options are currently exercisable and the remaining 14,000 options vest in 2 equal installments beginning on January 2, 2005.